Luminex Revenues Up 11 Percent in Q1, but Fall Short of Wall Street Expectations | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Luminex fell around 10 percent in early Friday trade after the firm reported late Thursday that its first-quarter revenues rose 11 percent but fell short of analysts' expectations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.